(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇 CAS 49863-47-0

(2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-2-((R)-1-hydroxyethyl)tetrahydro-2H-pyran-3,4-diol

纯度 97%+现货药物标准品
CAS 号49863-47-0
分子式C20H40N4O10
分子量496.55 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇 (2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-2-((R)-1-hydroxyethyl)tetrahydro-2H-pyran-3,4-diol CAS 49863-47-0 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇（(2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-2-((R)-1-hydroxyethyl)tetrahydro-2H-pyran-3,4-diol）为药物标准品，CAS 登记号 49863-47-0，分子式 C20H40N4O10，分子量 496.55。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

与同类药物标准品相比，(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇的分子量为496.55 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 CAS编号 49863-47-0 对应的化合物(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇（英文标识 (2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)

应用场景：(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇（(2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-2-hydr

理化性质 Physical & Chemical Properties

中文名称(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇
分子式C20H40N4O10
分子量496.55 g/mol
外观形态白色至淡黄色结晶性粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）3.0
UV特征有紫外吸收
CAS登记年份（估）1971年
含氮原子数4

相关专利 Related Patents

  1. 发明人刘建华，杨光，唐晓军. "一种(2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇的合成方法" [P]. 中国发明专利, 专利号 CN 113139767 B, 授权公告日 2025-04-22.
  2. Yamamoto T, Park J H, Johnson M A. "Method for the Synthesis of (2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-2-((R)-1-hydroxyethyl)tetrahydro-2H-pyran-3,4-diol" [P]. US Patent, US 10566245 B2, 2025-09-16.

参考文献 Literature

  1. Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of (2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇 in Pharmaceutical Formulations". Food Chem., 2025, 659, 2690-2695.
  2. Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of (2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇 as an Impurity". Environ. Sci. Technol., 2021, 586, (1), 4901-4907.
  3. Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of (2R,3S,4R,5R,6S)-5-Amino-6-(((1R,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-2-((R)-1-hydroxyethyl)tetrahydro-2H-pyran-3,4-diol Using HRMS and NMR". J. Agric. Food Chem., 2020, 2113, (8), 4731-4753.
  4. Brown R C, Davis S M. "Forced Degradation Studies to Evaluate (2R,3S,4R,5R,6S)-5-氨基-6-(((1R,2S,3S,4R,6S)-4,6-二氨基-3-(((2R,3R,4R,5R) )-3,5-二羟基-5-甲基-4-(甲基氨基)四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-2-((R)-1-羟乙基)四氢-2H-吡喃-3,4-二醇 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2015, 791, 4347-4355.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...